DK0817637T3 - Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC - Google Patents
Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTCInfo
- Publication number
- DK0817637T3 DK0817637T3 DK96911953T DK96911953T DK0817637T3 DK 0817637 T3 DK0817637 T3 DK 0817637T3 DK 96911953 T DK96911953 T DK 96911953T DK 96911953 T DK96911953 T DK 96911953T DK 0817637 T3 DK0817637 T3 DK 0817637T3
- Authority
- DK
- Denmark
- Prior art keywords
- ftc
- zidovudine
- synergistic combinations
- synergistic
- combinations
- Prior art date
Links
- 239000011885 synergistic combination Substances 0.000 title 1
- 229960002555 zidovudine Drugs 0.000 title 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9506490.3A GB9506490D0 (en) | 1995-03-30 | 1995-03-30 | Antiviral combinations |
| GBGB9506489.5A GB9506489D0 (en) | 1995-03-30 | 1995-03-30 | Antiviral combinations |
| PCT/EP1996/001352 WO1996030025A1 (en) | 1995-03-30 | 1996-03-28 | Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0817637T3 true DK0817637T3 (da) | 2002-11-11 |
Family
ID=26306774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96911953T DK0817637T3 (da) | 1995-03-30 | 1996-03-28 | Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6417191B1 (cs) |
| EP (1) | EP0817637B1 (cs) |
| JP (1) | JP2954357B2 (cs) |
| KR (1) | KR100542536B1 (cs) |
| CN (1) | CN1103593C (cs) |
| AP (1) | AP652A (cs) |
| AT (1) | ATE220551T1 (cs) |
| AU (1) | AU715213B2 (cs) |
| BR (3) | BR9607851B1 (cs) |
| CA (1) | CA2216634C (cs) |
| CZ (1) | CZ295940B6 (cs) |
| DE (3) | DE69622386T2 (cs) |
| DK (1) | DK0817637T3 (cs) |
| EA (1) | EA000626B3 (cs) |
| EE (1) | EE04047B1 (cs) |
| ES (1) | ES2179193T3 (cs) |
| FR (1) | FR05C0022I2 (cs) |
| GE (1) | GEP20022647B (cs) |
| HU (1) | HU224010B1 (cs) |
| IL (1) | IL117727A (cs) |
| LU (1) | LU91171I2 (cs) |
| MX (1) | MX9707316A (cs) |
| MY (1) | MY115461A (cs) |
| NL (1) | NL300195I2 (cs) |
| NO (2) | NO313787B1 (cs) |
| NZ (1) | NZ306419A (cs) |
| OA (1) | OA10616A (cs) |
| PL (1) | PL187085B1 (cs) |
| PT (1) | PT817637E (cs) |
| RO (1) | RO117995B1 (cs) |
| SI (1) | SI0817637T1 (cs) |
| SK (1) | SK283825B6 (cs) |
| TR (1) | TR199701074T1 (cs) |
| UA (1) | UA60293C2 (cs) |
| WO (1) | WO1996030025A1 (cs) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1228026A (zh) * | 1996-06-25 | 1999-09-08 | 葛兰素集团有限公司 | 用于治疗hiv感染的含有vx478、叠氮胸苷、ftc和/或3tc的复方制剂 |
| US6113920A (en) * | 1996-10-31 | 2000-09-05 | Glaxo Wellcome Inc. | Pharmaceutical compositions |
| TW536403B (en) * | 1997-03-24 | 2003-06-11 | Glaxo Group Ltd | An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy |
| AU769660B2 (en) * | 1997-05-17 | 2004-01-29 | Glaxo Group Limited | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
| GB9709945D0 (en) * | 1997-05-17 | 1997-07-09 | Glaxo Group Ltd | A novel salt |
| WO1998052570A1 (en) * | 1997-05-17 | 1998-11-26 | Glaxo Group Limited | Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
| GB9809213D0 (en) * | 1998-04-29 | 1998-07-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| AU4219799A (en) * | 1998-05-29 | 1999-12-13 | University Of Florida | Combination therapy for treatment of fiv infection |
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US6432966B2 (en) | 1999-10-29 | 2002-08-13 | Smithkline Beecham Corporation | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| AP2220A (en) * | 2001-05-11 | 2011-03-24 | Cipla Medpro Pty Ltd | Pharmaceutical composition. |
| AR040242A1 (es) * | 2002-06-04 | 2005-03-23 | Glaxo Group Ltd | Composiciones farmaceuticas |
| US20040224917A1 (en) | 2003-01-14 | 2004-11-11 | Gilead Sciences, Inc. | Compositions and methods for combination antiviral therapy |
| JP4485520B2 (ja) | 2003-03-24 | 2010-06-23 | エフ．ホフマン−ラ ロシュ アーゲー | 逆転写酵素阻害剤としてのベンジル−ピリダジノン類 |
| EP2270511A3 (en) | 2003-10-24 | 2011-08-24 | Immunaid Pty Ltd | Method of therapy |
| TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
| AU2006303368B2 (en) | 2005-10-19 | 2011-05-26 | F. Hoffmann-La Roche Ag | Non-Nucleoside Reverse Transcriptase Inhibitors |
| JP5415957B2 (ja) | 2006-12-13 | 2014-02-12 | エフ．ホフマン−ラ ロシュ アーゲー | 非ヌクレオシド逆転写酵素阻害剤としての２−（ピペリジン−４−イル）−４−フェノキシ−又はフェニルアミノ−ピリミジン誘導体 |
| AU2008213744B2 (en) * | 2007-02-09 | 2013-12-05 | Alphapharm Pty Ltd | A dosage form containing two or more active pharmaceutical ingredients in different physical forms |
| WO2010135781A1 (en) | 2009-05-27 | 2010-12-02 | Immunaid Pty Ltd | Methods of treating diseases |
| LT3127542T (lt) | 2010-01-27 | 2018-11-26 | Viiv Healthcare Company | Antivirusinė terapija |
| HK1220390A1 (zh) | 2013-08-29 | 2017-05-05 | Teva Pharmaceutical Industries Ltd. | 包括恩曲他滨，替诺福韦，达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂 |
| WO2015155673A1 (en) | 2014-04-08 | 2015-10-15 | Teva Pharmaceutical Industries Ltd | Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir |
| US11311512B2 (en) | 2014-08-12 | 2022-04-26 | Monash University | Lymph directing prodrugs |
| US11738087B2 (en) | 2015-09-08 | 2023-08-29 | Monash University | Lymph directing prodrugs |
| CA3077739A1 (en) | 2017-08-29 | 2019-03-07 | Puretech Lyt, Inc. | Lymphatic system-directing lipid prodrugs |
| US11883497B2 (en) | 2017-08-29 | 2024-01-30 | Puretech Lyt, Inc. | Lymphatic system-directing lipid prodrugs |
| US11304954B2 (en) | 2017-12-19 | 2022-04-19 | Puretech Lyt, Inc. | Lipid prodrugs of mycophenolic acid and uses thereof |
| US11608345B1 (en) | 2017-12-19 | 2023-03-21 | Puretech Lyt, Inc. | Lipid prodrugs of rapamycin and its analogs and uses thereof |
| JP2023514147A (ja) | 2020-02-05 | 2023-04-05 | ピュアテック・エル・ワイ・ティ・インコーポレイテッド | 神経ステロイドの脂質プロドラッグ |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
| US5047407A (en) | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| US5122517A (en) | 1988-06-10 | 1992-06-16 | Regents Of The University Of Minnesota | Antiviral combination comprising nucleoside analogs |
| GB8815265D0 (en) * | 1988-06-27 | 1988-08-03 | Wellcome Found | Therapeutic nucleosides |
| US5204466A (en) | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
| GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
| DE69206876T3 (de) * | 1991-05-16 | 2004-08-12 | Glaxo Group Ltd., Greenford | Nukleosidanalogen enthaltende Antiviren-Zubereitungen |
| ES2138624T3 (es) * | 1992-05-13 | 2000-01-16 | Wellcome Found | Combinaciones terapeuticas. |
| US5723490A (en) | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
| GB9417249D0 (en) | 1994-08-26 | 1994-10-19 | Wellcome Found | A novel salt |
| US5869461A (en) | 1995-03-16 | 1999-02-09 | Yale University | Reducing toxicity of L-nucleosides with D-nucleosides |
| CN1306430A (zh) | 1996-06-25 | 2001-08-01 | 葛兰素集团有限公司 | 用于治疗hiv感染的含有vx478、叠氮胸苷和/或1592u89的复方制剂 |
| CN1228026A (zh) | 1996-06-25 | 1999-09-08 | 葛兰素集团有限公司 | 用于治疗hiv感染的含有vx478、叠氮胸苷、ftc和/或3tc的复方制剂 |
| DE10226522A1 (de) * | 2002-06-14 | 2003-12-24 | Degussa | Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung |
-
1996
- 1996-03-27 MY MYPI96001152A patent/MY115461A/en unknown
- 1996-03-28 CN CN96194050A patent/CN1103593C/zh not_active Expired - Lifetime
- 1996-03-28 AU AU54972/96A patent/AU715213B2/en not_active Expired
- 1996-03-28 SK SK1295-97A patent/SK283825B6/sk not_active IP Right Cessation
- 1996-03-28 DE DE69622386T patent/DE69622386T2/de not_active Expired - Lifetime
- 1996-03-28 EA EA199700203A patent/EA000626B3/ru not_active IP Right Cessation
- 1996-03-28 ES ES96911953T patent/ES2179193T3/es not_active Expired - Lifetime
- 1996-03-28 BR BRPI9607851-0A patent/BR9607851B1/pt active IP Right Grant
- 1996-03-28 DE DE200512000029 patent/DE122005000029I1/de active Pending
- 1996-03-28 MX MX9707316A patent/MX9707316A/es active IP Right Grant
- 1996-03-28 UA UA97094740A patent/UA60293C2/uk unknown
- 1996-03-28 PT PT96911953T patent/PT817637E/pt unknown
- 1996-03-28 HU HU9801571A patent/HU224010B1/hu active Protection Beyond IP Right Term
- 1996-03-28 JP JP8528931A patent/JP2954357B2/ja not_active Expired - Lifetime
- 1996-03-28 SI SI9630494T patent/SI0817637T1/xx unknown
- 1996-03-28 US US08/930,225 patent/US6417191B1/en not_active Expired - Lifetime
- 1996-03-28 BR BRPI9612992-1A patent/BRPI9612992B1/pt not_active IP Right Cessation
- 1996-03-28 EE EE9700240A patent/EE04047B1/xx not_active IP Right Cessation
- 1996-03-28 AP APAP/P/1997/001089A patent/AP652A/en active
- 1996-03-28 WO PCT/EP1996/001352 patent/WO1996030025A1/en active IP Right Grant
- 1996-03-28 AT AT96911953T patent/ATE220551T1/de active
- 1996-03-28 GE GEAP19963898A patent/GEP20022647B/en unknown
- 1996-03-28 EP EP96911953A patent/EP0817637B1/en not_active Expired - Lifetime
- 1996-03-28 CA CA002216634A patent/CA2216634C/en not_active Expired - Lifetime
- 1996-03-28 PL PL96322532A patent/PL187085B1/pl unknown
- 1996-03-28 DE DE1996622386 patent/DE122005000029I2/de active Active
- 1996-03-28 CZ CZ19973090A patent/CZ295940B6/cs not_active IP Right Cessation
- 1996-03-28 TR TR97/01074T patent/TR199701074T1/xx unknown
- 1996-03-28 BR BRPI9607851A patent/BRPI9607851B8/pt unknown
- 1996-03-28 DK DK96911953T patent/DK0817637T3/da active
- 1996-03-28 RO RO97-01795A patent/RO117995B1/ro unknown
- 1996-03-28 KR KR1019970706824A patent/KR100542536B1/ko not_active Expired - Lifetime
- 1996-03-28 NZ NZ306419A patent/NZ306419A/xx not_active IP Right Cessation
- 1996-03-29 IL IL11772796A patent/IL117727A/xx not_active IP Right Cessation
-
1997
- 1997-09-17 OA OA70075A patent/OA10616A/en unknown
- 1997-09-29 NO NO19974510A patent/NO313787B1/no not_active IP Right Cessation
-
2005
- 2005-05-04 LU LU91171C patent/LU91171I2/fr unknown
- 2005-05-09 NL NL300195C patent/NL300195I2/nl unknown
- 2005-05-09 FR FR05C0022C patent/FR05C0022I2/fr active Active
- 2005-05-24 NO NO2005014C patent/NO2005014I2/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0817637T3 (da) | Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC | |
| NO983965D0 (no) | Polymer-organoleire-kompositter og deres fremstilling | |
| NO972983D0 (no) | Sulfonamider og deres anvendelse | |
| DK0832104T3 (da) | Dolastatinderivater, deres fremstilling og anvendelse | |
| DK0832082T3 (da) | N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister | |
| NO964958D0 (no) | Aluminium-scandiumlegeringer og deres anvendelse | |
| DK0906292T3 (da) | Triazolylmercaptider og deres anvendelse som mikrobicider | |
| NO933434D0 (no) | Piperidinderivater, deres fremstilling og anvendelse | |
| DK1019358T3 (da) | 3,3-diarylpropylaminer, deres anvendelse og fremstilling | |
| ATE357459T1 (de) | Antikörper gegen mensliches il-12 | |
| NO20006488D0 (no) | Sammensetning og anvendelse | |
| DK1112003T3 (da) | Ny sammensætning og anvendelse | |
| DK0770059T3 (da) | Substituerede benzamidiner, deres fremstilling og deres anvendelse som lægemidler | |
| DK0804078T3 (da) | Sammensætning og anvendelse deraf | |
| NO995513L (no) | N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK- | |
| NO986034D0 (no) | Kombinasjoner omfattende VX 478, ZidovudÞn, FTC og/eller 3TC for anvendelse | |
| DK0898566T3 (da) | Substituerede benzylaminer og anvendelse deraf til behandling af depression | |
| NO963723L (no) | Flytepunktnedsettende tilsetningsstoffer og deres anvendelse | |
| DK60893D0 (da) | Piperidinderivater, deres fremstilling og anvendelse | |
| NO933435D0 (no) | Piperidinderivater, deres fremstilling og anvendelse | |
| DK278289A (da) | Ekspressionsvektorer, deres fremstilling og anvendelse til fremstilling af ufusionerede proteiner i mikroorganismer | |
| DK0776899T3 (da) | Mellemprodukter og deres anvendelse til fremstilling af N,N'-forbundne bisindolylmaleimider | |
| NO972821D0 (no) | 1-C-perfluoralkylglycosider, deres fremstilling og anvendelse | |
| NO986035D0 (no) | Kombinasjoner omfattende VX478, zidovudin og/eller 1592U89 for anvendelse i | |
| NO982242D0 (no) | Heparinanaloge kopolymerer, deres fremstilling og anvendelse |